Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau ProteoformsUnusual Whales·1 day ago, 12:02 PMNAUT-1.59%
PMGC Holdings Amends YuvaBio Development and License Deal to Launch Three-Phase Expansion ProgramTradingView·Sep 2 at 09:13 PM
Telix Pharmaceuticals shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $20 price target.benzinga_article·Sep 2 at 02:53 PMTLX+1.70%
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic ApplicationsUnusual Whales·Sep 1 at 11:46 AM
PROTAGENIC THERAPEUTICS INC C/WTS 26/04/2026 (TO PUR COM) | 10-Q: FY2026 Q2 Revenue: USD 0Earnings Watch·Nov 26, 2025 at 10:29 PMPTIXW0.00%
PROTAGENIC THERAPEUTICS INC C/WTS 26/04/2026 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -2.75Earnings Watch·May 13, 2025 at 07:23 PMPTIXW0.00%
